Last Price
10.91
Today's Change
+0.058 (0.53%)
Day's Change
10.83 - 11.55
Trading Volume
49,881
Profile
BNTC
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Jerel A. Banks M.D., Ph.D. Dr. Jerel A. Banks M.D., Ph.D.
Full Time Employees: 16 16
IPO Date: 2014-06-24 2014-06-24
CIK: 0001808898 0001808898
ISIN: US08205P2092 US08205P2092
CUSIP: 08205P100 08205P100
Beta: 0.90 0.90
Last Dividend: 0.00 0.00
Dcf Diff: 4.20 4.20
Dcf: 6.66 6.66
Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Uniqlo Owner Targets Higher Sales From Strong Western Market
2
CEO Morning Brief
3
4
CEO Morning Brief
5
CEO Morning Brief
#
Stock
Score
9
First Trust Exchange-Traded Fund Viii - Cboe Vest U S Equity Buffer and Premium Income Etf
625
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
